HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Guerlain

This article was originally published in The Rose Sheet

Executive Summary

Guerlain: New global ad campaign breaking in fall 1996 in conjunction with firm's worldwide launch of a "young, fresh" women's fragrance, Guerlain says. The campaign -- developed jointly by New York City-based Weiss Whitten Stagliano and Paris-based Australie -- will continue to focus on building the image of the Guerlain name as well as highlighting individual products, the firm noted ("The Rose Sheet" Sept. 12, 1994, p. 4). In addition, the campaign is designed to fit into European markets where Guerlain is already an established name, the company notes. Guerlain sought to streamline its global advertising into a "uniform creative platform [in order] to establish [the firm] as a major international force," Guerlain states. WWS and Australie entered into a strategic alliance to win the account...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002191

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel